MedPath

CERNEVIT POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

CERNEVIT POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

Commercialized
Register Number

60022

Prescription Type

Uso Hospitalario

Authorization Date

Feb 28, 1994

Dosage Form

LIOFILIZADO PARA SOLUCIÓN INYECTABLE

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number60022
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (12)

ASCORBICO ACIDOActive
Quantity: 125 mg
Name: ASCORBICO ACIDO
BIOTINAActive
Quantity: 0,069 mg
Name: BIOTINA
CIANOCOBALAMINAActive
Quantity: 0,006 mg
Name: CIANOCOBALAMINA
COCARBOXILASAActive
Quantity: 5,8 mg
Name: COCARBOXILASA
COLECALCIFEROLActive
Quantity: 220 UI
Name: COLECALCIFEROL
DEXPANTENOLActive
Quantity: 16,15 mg
Name: DEXPANTENOL
FOLICO ACIDOActive
Quantity: 0,414 mg
Name: FOLICO ACIDO
NICOTINAMIDAActive
Quantity: 46 mg
Name: NICOTINAMIDA
PIRIDOXINA HIDROCLORUROActive
Quantity: 5,5 mg
Name: PIRIDOXINA HIDROCLORURO
RETINOL PALMITATOActive
Quantity: 3500 UI
Name: RETINOL PALMITATO
RIBOFLAVINA FOSFATO SODIOActive
Quantity: 5,67 mg
Name: RIBOFLAVINA FOSFATO SODIO
TODO-ALFA-TOCOFEROLActive
Quantity: 10,2 mg
Name: TODO-ALFA-TOCOFEROL

ATC CLASSIFICATION (2)

B05X
B05XC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.